iAnthus owns and operates licensed cannabis cultivation, processing and dispensary facilities throughout the United States, providing investors diversified exposure to the U.S. regulated cannabis industry. Founded by entrepreneurs with decades of experience in operations, investment banking, corporate finance, law and healthcare services, iAnthus provides a unique combination of capital and hands-on operating and management expertise. iAnthus currently has a presence in 11 states and operates 35 dispensaries (AZ-4, MA-1, MD-3, FL-16, NY-3, CO-1, VT-1 and NM-6 where iAnthus has minority ownership).
In October 2018, iAnthus and MPX Bioceuticals announced an agreement to merge. The all-share transaction was the first of its kind, valued at C$835 million, making it the largest public cannabis transaction to date in the U.S. The transaction closed in February 2019. The combined created an entity with a significantly expanded footprint, with operations in 11 states, spanning both the east and west coasts, with a total addressable customer population of 121 million people and an over $10 billion 2019 market size. With this transformational expansion, iAnthus now has over 500,000 square feet of cultivation and processing space across the U.S.
iAnthus Capital Holdings Inc.
HQ: New York, New York
iAnthus owns and operates licensed cannabis cultivation, processing and dispensary facilities throughout the U.S., providing investors diversified exposure to the U.S. regulated cannabis industry.